Genmab — April 2018
-
Altså, der er jo stadig meget usikkerhed i markedet, masser af penge er ude og det her er jo stadig Biotek. Samtidigt er der masser af andre muligheder for at købe sig ind i temmeligt gode og mere sikre cases, når man har syn for hele verdens aktie marked.. tror der er brug for en længere periode med stærke salgs tal, der understøtter de høje peak salgstal og at andre forsøg kommer positivt ud..
-
Prothena’s lead drug has decisively failed a crucial Phase IIb study for rare, second-line cases of AL amyloidosis https://endpts.com/prothenas-lead-drug-neod001-just-imploded-in-2-late-stage-studies-and-theres-nothing-left-to-salvage/ Let's hope Dara will be more successful
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind